Kailera Therapeutics, Inc. · NASDAQ:KLRA
BCLS Fund IV Investments, L.P. reported a 17.43% stake in Kailera Therapeutics, Inc. (Schedule 13D)
Event Apr 16, 2026 · Filed Apr 23, 2026
BCLS Fund IV Investments, L.P. reported a 17.43% stake in Kailera Therapeutics, Inc., 22,583,268 shares, with active intent on Apr 16, 2026. Filed Apr 23, 2026 (Schedule 13D).
- Stake
- 17.43%
- Shares
- 22,583,268
- Intent
- Active
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BCLS Fund IV Investments, L.P. | 17.43% | 22,583,268 |
Source
Related
- Kailera Therapeutics, Inc.
- BCLS Fund IV Investments, L.P.
- Kailera Therapeutics, Inc. shareholders
- Schedule 13G · Canada Pension Plan Investment Board · Aug 14, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026
- Schedule 13G · Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Aug 5, 2026
- Form 4 · Renaud Ronald C JR · Jun 11, 2026
- Schedule 13D · BCPE Perseus Investor, LP · Apr 23, 2026